Evidence map›Paper›PMID 34832335›Full record

ArticleMaterials (Basel, Switzerland)2021

Parameters of Hemostasis in Sheep Implanted with Composite Scaffold Settled by Stimulated Mesenchymal Stem Cells-Evaluation of the Animal Model.

Aleksandra Pliszczak-Król, Zdzisław Kiełbowicz, Jarosław Król, Agnieszka Antończyk, Marianna Gemra, Piotr Skrzypczak, Przemysław Prządka, Dariusz Zalewski, Janusz Bieżyński, Jakub Nicpoń

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Aleksandra Pliszczak-KrólDepartment of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Zdzisław KiełbowiczDepartment and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Jarosław KrólDepartment of Pathology, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.ORCID 0000-0003-0012-4022
Agnieszka AntończykDepartment and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.ORCID 0000-0003-2065-4223
Marianna GemraDepartment of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Piotr SkrzypczakDepartment and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.ORCID 0000-0002-7586-0879
Przemysław PrządkaDepartment and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.ORCID 0000-0003-3596-2990
Dariusz ZalewskiDepartment of Genetics, Plant Breeding and Seed Production, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Janusz BieżyńskiDepartment and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Jakub NicpońDepartment and Clinic of Surgery, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland.
Wrocław University of Environmental and Life Sciences · PL

Funding

National Centre for Research and Development - Poland STRATEGMED3/306888/3/NCBR/2017
6 · The paper itself

Abstract

Implantation of composite scaffolds could be potentially associated with the risk of hemostatic disturbances in a recipient. However, there is a lack of information on possible alterations in clotting mechanisms resulting from such a procedure. The aim of the present work was to investigate changes in hemostatic parameters in sheep implanted with a scaffold composed of poly(ε-caprolactone) and hydroxyapatite and tricalcium phosphate (9:4.5:4.5), settled previously with mesenchymal stem cells stimulated by fibroblast growth factor-2 and bone morphogenetic protein-2. Nine Merino sheep were examined for 7 days, and measurements of clotting times (PT, aPTT), activities of antithrombin, protein C and clotting factors II-XII, and concentrations of fibrinogen and D-dimer were carried out before and 1 h, 24 h, 3 days and 7 days after scaffold implantation. The introduction of scaffold initially resulted in a slowdown of the clotting processes (most evident 24 h after surgery); PT and aPTT increased to 14.8 s and 33.9 s, respectively. From the third day onwards, most of these alterations began to return to normal values. The concentration of fibrinogen rose throughout the observation period (up to 8.4 g/L), mirroring the ongoing inflammatory reaction. However, no signals of significant disturbances in hemostatic processes were detected in the sheep tested.

Indexed as

coagulationfibrinolysishemostasisscaffold implantationsheep

Identifiers

PMID34832335
PMCPMC8622787
OpenAlexW3212342705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.